Sector Gamma As as of March 31, 2019
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 33 positions in its portfolio as reported in the March 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bristol Myers Squibb (BMY) | 10.4 | $65M | 1.4M | 47.71 | |
Abbott Laboratories (ABT) | 9.8 | $61M | 764k | 79.94 | |
Boston Scientific Corporation (BSX) | 6.9 | $43M | 1.1M | 38.38 | |
Gilead Sciences (GILD) | 6.0 | $38M | 579k | 65.01 | |
Baxter International (BAX) | 5.8 | $36M | 448k | 81.31 | |
Biogen Idec (BIIB) | 5.7 | $36M | 150k | 236.38 | |
PerkinElmer (RVTY) | 5.3 | $33M | 343k | 96.36 | |
NuVasive | 4.9 | $31M | 539k | 56.79 | |
Bio-Rad Laboratories (BIO) | 4.3 | $27M | 87k | 305.69 | |
Agilent Technologies Inc C ommon (A) | 3.6 | $23M | 280k | 80.38 | |
Incyte Corporation (INCY) | 3.6 | $23M | 261k | 86.01 | |
Mylan Nv | 3.6 | $22M | 791k | 28.34 | |
Ionis Pharmaceuticals (IONS) | 3.0 | $19M | 234k | 81.17 | |
Qiagen Nv (QGEN) | 2.6 | $16M | 397k | 40.68 | |
CVS Caremark Corporation (CVS) | 2.6 | $16M | 299k | 53.93 | |
Perrigo Company (PRGO) | 2.4 | $15M | 308k | 48.16 | |
Takeda Pharmaceutical (TAK) | 2.1 | $13M | 648k | 20.37 | |
Anthem (ELV) | 1.8 | $11M | 39k | 286.98 | |
Merck & Co (MRK) | 1.6 | $9.9M | 119k | 83.17 | |
Patterson Companies (PDCO) | 1.6 | $9.8M | 450k | 21.85 | |
Clovis Oncology | 1.5 | $9.4M | 380k | 24.82 | |
Portola Pharmaceuticals | 1.4 | $8.8M | 255k | 34.70 | |
Universal Health Services (UHS) | 1.4 | $8.4M | 63k | 133.77 | |
Cardinal Health (CAH) | 1.3 | $7.8M | 163k | 48.15 | |
Ptc Therapeutics I (PTCT) | 1.2 | $7.3M | 195k | 37.64 | |
Elanco Animal Health (ELAN) | 1.1 | $7.0M | 219k | 32.07 | |
Tenet Healthcare Corporation (THC) | 1.0 | $6.3M | 219k | 28.84 | |
McKesson Corporation (MCK) | 0.9 | $5.8M | 50k | 117.05 | |
Ultragenyx Pharmaceutical (RARE) | 0.7 | $4.6M | 66k | 69.36 | |
Agios Pharmaceuticals (AGIO) | 0.6 | $3.8M | 57k | 67.44 | |
Dr. Reddy's Laboratories (RDY) | 0.6 | $3.6M | 88k | 40.50 | |
Sangamo Biosciences (SGMO) | 0.4 | $2.3M | 239k | 9.54 | |
Lexicon Pharmaceuticals (LXRX) | 0.3 | $2.1M | 377k | 5.56 |